WELLINGTON MANAGEMENT GROUP LLP - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 78 filers reported holding UROGEN PHARMA LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$981,582
-56.6%
70,063
-70.6%
0.00%
Q4 2021$2,263,000
-57.6%
238,008
-25.0%
0.00%
-100.0%
Q3 2021$5,337,000
-74.8%
317,300
-77.2%
0.00%
-75.0%
Q2 2021$21,219,000
-34.2%
1,389,625
-16.0%
0.00%
-33.3%
Q1 2021$32,231,000
-2.8%
1,654,583
-10.1%
0.01%0.0%
Q4 2020$33,169,000
-13.9%
1,840,637
-7.8%
0.01%
-25.0%
Q3 2020$38,502,000
-26.4%
1,995,990
-0.3%
0.01%
-33.3%
Q2 2020$52,280,000
+167.5%
2,001,592
+82.7%
0.01%
+140.0%
Q1 2020$19,543,000
-52.1%
1,095,385
-10.3%
0.01%
-44.4%
Q4 2019$40,759,000
+29.8%
1,221,397
-7.3%
0.01%
+28.6%
Q3 2019$31,391,000
-38.4%
1,317,266
-7.0%
0.01%
-36.4%
Q2 2019$50,932,000
-5.1%
1,417,172
-2.4%
0.01%
-8.3%
Q1 2019$53,646,000
+28.0%
1,452,237
+49.2%
0.01%
+20.0%
Q4 2018$41,904,000
-10.7%
973,154
-2.1%
0.01%0.0%
Q3 2018$46,935,000
-4.4%
993,786
+0.7%
0.01%
-9.1%
Q2 2018$49,097,000
+5.1%
986,660
+5.0%
0.01%0.0%
Q1 2018$46,703,000
+141.8%
939,875
+81.1%
0.01%
+175.0%
Q4 2017$19,315,000
+111.8%
519,090
+79.5%
0.00%
+100.0%
Q3 2017$9,118,000
-32.9%
289,262
-61.6%
0.00%
-33.3%
Q2 2017$13,596,000752,7400.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders